Dr. Marra talks to Prof. Ahmed on focal therapy for low- or intermediate-risk PCa

They discuss the main reasons for the change in the new guidelines this year. Prof. Ahmed details the dangers of rapid dissemination. He also shares his expert opinion on how he positions focal therapy within the context of the PROTECT trial results. He concludes with information on other recent focal trials, such as the FARP trial.

To keep up to date with prostate cancer developments, you can also visit our educational platform, UROONCO Prostate Cancer.

For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates - Apple Podcasts, Spotify, Google Podcasts.